Investing Center Preview – Manage your investments and watch your net worth grow.
AMGN:NASDAQ – Large Cap Stock (Drug Manufacturers)
Amgen Inc – AMGN Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
296.47 | 6.18 (+2.13%) | 253.30 - 339.17 | 2.2 million (Below Avg) |
Market data as of 4:00PM 08/15/25. Quotes are delayed by at least 15 min.
Overview - AMGN
Open | 292.03 |
---|---|
Previous Close | 290.29 |
Day's Range | 290.58 - 296.99 |
Market Cap | 159.6B |
Avg Volume (10 Day) | 2.4M |
Price/Earnings (Trailing 12 Mo.) | 24.2x |
Earnings Per Share (Trailing 12 Mo.) | 4.244 |
Dividend Yield | 2.38 (3.21%) |
One-Click Scorecard - AMGN


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Pass |
Increased shareholder value? | Fail |
Consistently increased owner earnings? | Pass |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Pass |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Pass |
Borrows within reasonable limits? | Fail |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - AMGN
AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
PR Newswire - Tuesday 08/05/2025 4:01 PM ET
AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND
PR Newswire - Friday 08/01/2025 4:01 PM ET
AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS
PR Newswire - Thursday 07/31/2025 4:01 PM ET
Industry Position - AMGN
AMGN | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 18.57% | |
Net Income Growth (1yr) | -39.11% | |
Total Debt/Equity | 7.57 | |
LT Debt/Equity | 7.24 | |
Earnings Yield | 4.13% | |
Price/Sales | 4.59 |
Competitors - AMGN
Company | Last | Change |
---|---|---|
11592.00 | +0.05% | |
Gilead Sciences Inc | 118.37 | -0.55% |
Pfizer Inc | 25.14 | +0.12% |
99.49 | +0.93% | |
-- | -- |
Data is delayed by at least 15 min.